Purdue Pharma is testing Oxy on children in an effort to get approval for ages 6 and up.” Oh, when businesses lose their way, and forget about their mission (to be of benefit, the Hippocratic Oath) in pursuit of ever-greater riches.
OxyContin maker wants FDA backing to label addictive drug for 6-year-olds:
“The family-owned pharmaceutical company earned an estimated $2.8 billion in revenue last year from sales of the powerful opioid, part of the same drug family as morphine and heroin…The Purdue trial involves 154 children ages 6 to 16 and is slated for completion in August of next year, according to a filing submitted to the FDA. The document says that the study is currently recruiting participants.”
“There’s good medical evidence that suggests a brain that’s not fully mature is at greater risk at developing the disease of addiction,” said Andrew Kolodny, president of Physicians for Responsible Opioid Prescribing and the head of psychiatry at Maimonides Medical Center in New York City. The pediatric community underestimates those risks, he said, because they have given too much credence to drugmakers, who have systematically downplayed the dangers.
“Much of that misinformation (came from a) campaign funded by Purdue.” …Click here to read the rest at the Daily.
hot on elephant
Elephant Journal’s Holiday Gift Guide 636 shares A letter to the Anger that refuses to Leave Me. 549 shares Waylon’s favorite Ethical Gifts. 10 shares Join: Elephant’s Winter 2017 Academy. 28 shares Trevor Noah just won my Respect. 2,556 shares Year of the Fire Rooster 2017: What to Expect. 844 shares December Forecast: Letting Go of 2016 & Leaning into 2017 with Love. 6,578 shares These Tweets (and Retweets) actually Happened. 1,376 share How to Say Goodbye to that almost-great Love. 1,543 share For the Women who are Trying to Do & Be Everything to Everyone. 3,141 shares